Stocktoria

Orchestra BioMed Holdings, Inc. OBIO

Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-08-04
Chart by TradingView
5/9
Piotroski F — financial health
-7.02
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$33.5M$2.6M$2.8M$3.5M
Operating income-$51.8M-$64.3M-$51.5M-$32.7M-$394,756
Net income-$52.7M-$61.0M-$49.1M-$33.6M-$378,753
Operating cash flow-$49.0M-$50.6M-$46.1M-$29.3M-$272,362
Free cash flow-$49.5M-$50.8M-$46.2M-$29.9M
Total assets$114.9M$76.2M$95.2M$95.6M$161.8M
Total liabilities$51.5M$43.2M$27.2M$43.0M$5.8M
Shareholders' equity$53.6M$33.0M$68.0M$52.5M-$19.8M
Ratios
Operating margin-154.7%-2437.5%-1866.2%-924.3%
Net margin-157.4%-2313.3%-1779.7%-951.3%
FCF margin-147.7%-1927.5%-1674.1%-845.7%
Return on assets-45.9%-80.1%-51.6%-35.2%-0.2%
Return on equity-98.4%-185.2%-72.2%-64.0%1.9%
Debt / equity0.28×0.46×
Current ratio6.454.277.954.5610.88
Revenue growth1169.2%-4.4%-21.9%

Notable holders (13F)

InvestorSharesValue
Point72 Asset Management, L.P.87,888$373,524
RENAISSANCE TECHNOLOGIES LLC70,900$301,325

Why these scores methodology →

Piotroski F-score: 5/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: -7.02 (distress)

  • Working capital / assets 0.794
  • Retained earnings / assets -3.157
  • EBIT / assets -0.451
  • Equity / liabilities 1.041

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001814114 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.